# Chronic Kidney Disease and Cardiovascular Disease Risk Assessment

> **NCT03975439** · — · WITHDRAWN · sponsor: **Pacific Northwest University of Health Sciences**

## Conditions studied

- Chronic Kidney Diseases
- Diabetes Mellitus
- Hypertension

## Interventions

- **DIAGNOSTIC_TEST:** Hemoglobin A1C
- **DIAGNOSTIC_TEST:** Urinalysis
- **DIAGNOSTIC_TEST:** Whole blood creatinine level

## Key facts

- **NCT ID:** NCT03975439
- **Lead sponsor:** Pacific Northwest University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-02-01
- **Primary completion:** 2020-02-05
- **Final completion:** 2020-02-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Decided to do smaller pilot study instead
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03975439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03975439, "Chronic Kidney Disease and Cardiovascular Disease Risk Assessment". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT03975439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*